{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T17:14:11Z","timestamp":1776532451216,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2022ER260500"],"award-info":[{"award-number":["2022ER260500"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-00165946"],"award-info":[{"award-number":["RS-2022-00165946"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cmi.2024.01.010","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T02:06:10Z","timestamp":1705802770000},"page":"653-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: implications of immune imprinting and interference"],"prefix":"10.1016","volume":"30","author":[{"given":"Min Joo","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hea Jeon","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Youn","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Jung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jin","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chulwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Kyung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WonSeok","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoungguk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.01.010_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104554","article-title":"Immunopathological similarities between COVID-19 and influenza: investigating the consequences of co-infection","volume":"152","author":"Khorramdelazad","year":"2021","journal-title":"Microb Pathog"},{"key":"10.1016\/j.cmi.2024.01.010_bib4","article-title":"Vaccines and related biological products advisory committee","volume":"2023","year":"2023","journal-title":"FDA Brief Document: Future Vaccination Regimens Addressing COVID-19 Meet"},{"key":"10.1016\/j.cmi.2024.01.010_bib5","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(22)00383-X","article-title":"SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses","volume":"399","author":"Swets","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.01.010_bib6","series-title":"Presented at the advisory committee on immunization practices meeting, Atlanta, GA","article-title":"COVID-19 Vaccine: considerations for future planning","author":"Oliver","year":"2023"},{"key":"10.1016\/j.cmi.2024.01.010_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2213-2600(21)00409-4","article-title":"Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial","volume":"10","author":"Toback","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2024.01.010_bib9","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/S0140-6736(21)02329-1","article-title":"Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial","volume":"398","author":"Lazarus","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.01.010_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S2213-2600(21)00557-9","article-title":"Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged \u226565 years: a phase 2, randomised, open-label study","volume":"10","author":"Izikson","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2024.01.010_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cmi.2022.12.008","article-title":"Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers","volume":"29","author":"Radner","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.01.010_bib12","article-title":"Timing and sequence of vaccination against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial","volume":"29","author":"Dulfer","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.cmi.2024.01.010_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01390-2022","article-title":"Immunogenicity and safety of co-administration of COVID-19 and influenza vaccination","volume":"61","author":"Wagenh\u00e4user","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2024.01.010_bib16","article-title":"Guidelines on clinical evaluation of vaccines: regulatory expectations","volume":"1004","year":"2017","journal-title":"World Health Organ Tech Rep S"},{"key":"10.1016\/j.cmi.2024.01.010_bib17","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.01.010_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMc2107799","article-title":"Infection and vaccine-induced neutralizing-antibody responses to the SARS-CoV-2 B.1.617 variants","volume":"385","author":"Edara","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2024.01.010_bib19","first-page":"827","article-title":"Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection","volume":"3","author":"Curlin","year":"2022","journal-title":"Infect Med"},{"key":"10.1016\/j.cmi.2024.01.010_bib20","article-title":"Safety and immunogenicity of synchronous COVID19 and influenza vaccination","volume":"2","author":"Baj","year":"2022","journal-title":"J\u00a0Clin Virol Plus"},{"key":"10.1016\/j.cmi.2024.01.010_bib21","article-title":"Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: an open question","volume":"18","author":"Stefanizzi","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2024.01.010_bib22","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s40121-023-00863-5","article-title":"Safety and immunogenicity of the BNT162b2 vaccine coadministered with seasonal inactivated influenza vaccine in adults","volume":"12","author":"Murdoch","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2024.01.010_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32813","article-title":"Immunogenicity and reactogenicity of coadministration of COVID-19 and influenza vaccines","volume":"6","author":"Gonen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2024.01.010_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2017.04.008","article-title":"Original antigenic sin: a comprehensive review","volume":"83","author":"Vatti","year":"2017","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cmi.2024.01.010_bib25","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1016\/j.vaccine.2021.08.092","article-title":"Association of flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers","volume":"39","author":"Pallikkuth","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.01.010_bib26","doi-asserted-by":"crossref","first-page":"108441","DOI":"10.1016\/j.isci.2023.108441","article-title":"Influenza-A mediated pre-existing immunity level to SARS-CoV-2 could predict early COVID-19 outbreak dynamics","volume":"26","author":"Almaz\u00e1n","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.cmi.2024.01.010_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1167214","article-title":"Immune interference in effectiveness of influenza and COVID-19 vaccination","volume":"14","author":"Xie","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2024.01.010_bib28","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/infdis\/jiad073","article-title":"Bivalent COVID vaccines; can the original antigenic sin be forgiven?","volume":"227","author":"Blankson","year":"2023","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.010_bib29","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1016\/j.vaccine.2022.07.021","article-title":"Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: a randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China","volume":"40","author":"Shenyu","year":"2022","journal-title":"Vaccine"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:50:56Z","timestamp":1746103856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1198743X24000302"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.01.010","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: implications of immune imprinting and interference","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}